Castellum, Inc.
CTM NYSE Services-Management Consulting Services Financials FY2020βFY2025
Last close Β· Oct 23, 2026
$0.54
4.2%What Castellum, Inc. does
No business description yet.
- Legal name
- Castellum, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 9, 2026
- Accession Β· CIK
- 0001877939-26-000016
0001877939
Revenue and margins
Castellum, Inc. had $52.9M of revenue in fiscal 2025, up 18.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$2.1M in fiscal 2025, β4.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Castellum, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 68.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Castellum, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.0M | $4.6M | $1.8M | $12.3M | $14.9M |
| Debt incl. finance leases | $8.4M | $8.4M | $8.1M | $8.0M | β |
| Debt / equity | 0.5x | 0.5x | 0.6x | 0.4x | β |
| Interest coverage | β4.7x | β6.5x | β11.9x | β34.6x | β |
| Current ratio | 1.6x | 1.4x | 1.2x | 1.9x | 4.4x |
| Quick ratio | 1.6x | 1.4x | 1.2x | 1.9x | 4.4x |
| Total assets | $30.8M | $33.0M | $30.1M | $37.8M | $41.9M |
| Total liabilities | $15.4M | $15.5M | $17.2M | $17.7M | $6.2M |
| Shareholders' equity | $15.3M | $17.5M | $12.9M | $20.2M | $35.8M |
| Net debt (β = net cash) | $6.4M | $3.7M | $6.2M | β$4.3M | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 4 / 9 | 2 / 9 | 5 / 9 | 4 / 8 |
| Accruals ratio | β | β20.1% | β49.8% | β49.2% | β32.7% | β1.1% |
| Altman Z'' | β | β1.16 | β2.84 | β7.36 | β3.17 | 4.23 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $13.3M | $25.1M | $42.2M | $45.2M | $44.8M | $52.9M |
| Net interest income | β$2.3M | β$2.5M | β$4.0M | β$3.2M | β$1.2M | $0.0M |
| Gross profit | $6.2M | $11.1M | $17.6M | $18.7M | $18.3M | $19.4M |
| Operating income | β$1.5M | β$7.7M | β$10.0M | β$16.7M | β$7.2M | β$2.8M |
| Interest expense | $0.7M | $1.6M | $1.5M | $1.4M | $0.2M | $0.0M |
| Pretax income | β$3.8M | β$10.2M | β$14.1M | β$19.1M | β$9.9M | β$2.2M |
| Income tax | β$1.1M | β$2.7M | $0.8M | β$1.3M | $0.1M | $0.2M |
| Net income | β$2.7M | β$7.5M | β$14.9M | β$17.8M | β$10.0M | β$2.4M |
| Net income to common | β$2.7M | β$7.6M | β$15.0M | β$17.9M | β$10.1M | β$2.5M |
| Diluted EPS | β$0.17 | β$0.41 | β$0.55 | β$0.38 | β$0.18 | β$0.03 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.05B | 0.06B | 0.09B |
| Cash flow | ||||||
| Cash from operations | $1.0M | β$1.4M | $1.0M | β$2.3M | $1.1M | β$1.9M |
| Capital expenditure | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | $0.2M |
| Free cash flow | $1.0M | β$1.4M | $0.9M | β$2.3M | $1.1M | β$2.1M |
| Depreciation and amortization | $1.8M | $1.9M | $2.0M | $2.5M | $2.2M | $1.5M |
| Stock-based compensation | $0.9M | $6.9M | $8.8M | $7.5M | $5.4M | $2.5M |
| Acquisitions | $0.0M | $0.0M | $0.3M | β | β | β |
| Balance sheet | ||||||
| Cash and short-term investments | $2.4M | $2.0M | $4.6M | $1.8M | $12.3M | $14.9M |
| Total debt | β | $8.4M | $8.4M | $8.1M | $8.0M | β |
| Current assets | β | $8.2M | $10.7M | $9.5M | $18.9M | $24.6M |
| Current liabilities | β | $5.1M | $7.8M | $8.0M | $9.8M | $5.6M |
| Property and equipment, net | β | $0.1M | $0.2M | $0.3M | $0.2M | $0.2M |
| Goodwill | $4.1M | $14.1M | $15.5M | $10.7M | $10.7M | $10.7M |
| Intangible assets | β | $7.6M | $6.6M | $9.0M | $6.8M | $5.4M |
| Total assets | β | $30.8M | $33.0M | $30.1M | $37.8M | $41.9M |
| Total liabilities | β | $15.4M | $15.5M | $17.2M | $17.7M | $6.2M |
| Shareholders' equity | $2.6M | $15.3M | $17.5M | $12.9M | $20.2M | $35.8M |
| Margins | ||||||
| Gross margin | 46.3% | 44.2% | 41.7% | 41.3% | 40.8% | 36.6% |
| Operating margin | β11.0% | β30.8% | β23.6% | β36.8% | β16.2% | β5.3% |
| EBITDA margin | 2.7% | β23.3% | β18.8% | β31.3% | β11.2% | β2.5% |
| Net margin | β20.3% | β30.1% | β35.3% | β39.3% | β22.3% | β4.5% |
| FCF margin | 7.5% | β5.4% | 2.1% | β5.0% | 2.5% | β4.0% |
| Net interest share of revenue | β17.2% | β10.0% | β9.5% | β7.2% | β2.6% | 0.0% |
| Returns | ||||||
| Return on capital | β | β28.1% | β37.0% | β68.6% | β35.9% | β |
| Return on capital employed | β | β30.1% | β39.4% | β75.3% | β25.9% | β7.8% |
| Return on equity | β103.8% | β84.2% | β90.8% | β116.8% | β60.2% | β8.6% |
| Return on assets | β | β24.5% | β46.7% | β56.4% | β29.4% | β6.0% |
| Return on tangible equity | β | β | β | β | β372.5% | β12.7% |
| Growth | ||||||
| Revenue growth | β | 87.9% | 68.3% | 7.2% | β1.1% | 18.1% |
| FCF growth | β | β235.6% | β | β353.4% | β | β288.0% |
| Share count change | β | 12.4% | 50.4% | 71.8% | 17.2% | 68.1% |
| Financial health | ||||||
| Debt / equity | β | 0.5x | 0.5x | 0.6x | 0.4x | β |
| Interest coverage | β2.0x | β4.7x | β6.5x | β11.9x | β34.6x | β |
| Current ratio | β | 1.6x | 1.4x | 1.2x | 1.9x | 4.4x |
| Quick ratio | β | 1.6x | 1.4x | 1.2x | 1.9x | 4.4x |
| Capital allocation | ||||||
| Capex / revenue | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | 0.3% |
| Stock comp / revenue | 7.0% | 27.6% | 20.8% | 16.6% | 12.1% | 4.7% |
| Quality scores | ||||||
| Piotroski F-score | β | β | 4.0 | 2.0 | 5.0 | 4.0 |
| Altman Z'' | β | β1.2 | β2.8 | β7.4 | β3.2 | 4.2 |
| Accruals ratio | β | β20.1% | β49.8% | β49.2% | β32.7% | β1.1% |
Source: SEC EDGAR XBRL filings (CIK 0001877939). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.